The vaccine will be trialled on up to 510 people out of a group of 1,112 aged 18 to 55
Oxford University researchers will begin human trials of a potential Covid-19 vaccine in the UK from Thursday, reports BBC quoting UK Health Secretary Matt Hancock.
"The Government will give the scientists an extra £20million to help with their trials and a further £22.5m to a project at Imperial College London," Hancock added.
Matt Hancock also said he was 'throwing everything at' Britain's attempt to develop the first vaccine in the world, reports Mail Online.
The vaccine Oxford University researchers developed is known as ChAdOx1 nCoV-19.
The vaccine will be trialled on up to 510 people out of a group of 1,112 aged 18 to 55. Oxford recruiting volunteers in London, Bristol, Oxford and Southampton.
This is the first British-made vaccine to go into real-world trials and carries with it huge hopes that it will provide a key to getting out of lockdown caused by the global spread of Covid-19.